• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS STENT SYSTEM 4.5 X 21MM WITHOUT TIP; STENT, INTRACRANIAL NEUROVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS STENT SYSTEM 4.5 X 21MM WITHOUT TIP; STENT, INTRACRANIAL NEUROVASCULAR Back to Search Results
Catalog Number M003SZAS45210
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Neurological Deficit/Dysfunction (1982); Thrombosis (2100); Thrombus (2101)
Event Date 09/26/2019
Event Type  Injury  
Manufacturer Narrative
Subject device remains implanted.
 
Event Description
It was reported that the patient presented with onset of left middle cerebral artery (mca) syndrome that was identified as a dissected occlusion of the left cervical carotid.The patient underwent successful angioplasty and stenting with 3 stents including the subject device.The three overlapping stents achieved excellent endoluminal reconstruction of the vessel with recananalization of the carotid.Six day-post-procedure, the patient presented with right hemiplegia and evidence on computed tomography (ct) angiography of occlusion through the stented segment.Angiography demonstrated thrombosis of the cervical internal carotid artery throughout the stented segment, without apparent intracranial reconstitution.Aspiration was performed, with persistent occlusion.After multiple attempts to navigate a catheter through the stented segment, it was apparent the subject stent bridging the two largest stents of the cervical carotid artery was compromised.A (non-stryker) balloon and (non-stryker) stent were utilized to reopen the artery; additional angiography demonstrated an obvious intracranial dissection of the left petrous internal carotid artery as well, with persistent thrombosis of one large m2 branch of the mca.Because of the length of the procedure and the complexity, it was elected at this point to conclude any further intervention.According to the physician, the reason for in-stent thrombosis was the underlying dissection and the subsequent entire stent construct thrombosed.According to the physician, the reason for intracranial dissection of the left petrous internal carotid artery observed six-day-post-procedure was the difficulty to access distally to subject stent with a non stryker micro-wire dissection.
 
Event Description
It was reported that the patient presented with onset of left middle cerebral artery (mca) syndrome that was identified as a dissected occlusion of the left cervical carotid.The patient underwent successful angioplasty and stenting with 3 stents including the subject device.The three overlapping stents achieved excellent endoluminal reconstruction of the vessel with recentralization of the carotid.Six day-post-procedure, the patient presented with right hemiplegia and evidence on computed tomography (ct) angiography of occlusion through the stented segment.Angiography demonstrated thrombosis of the cervical internal carotid artery throughout the stented segment, without apparent intracranial reconstitution.Aspiration was performed, with persistent occlusion.After multiple attempts to navigate a catheter through the stented segment, it was apparent the subject stent bridging the two largest stents of the cervical carotid artery was compromised.A (non-stryker) balloon and (non-stryker) stent were utilized to reopen the artery; additional angiography demonstrated an obvious intracranial dissection of the left petrous internal carotid artery as well, with persistent thrombosis of one large m2 branch of the mca.Because of the length of the procedure and the complexity, it was elected at this point to conclude any further intervention.According to the physician, the reason for in-stent thrombosis was the underlying dissection and the subsequent entire stent construct thrombosed.According to the physician, the reason for intracranial dissection of the left petrous internal carotid artery observed six-day-post-procedure was the difficulty to access distally to subject stent with a non stryker micro-wire dissection.
 
Manufacturer Narrative
The device history record confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.The reported event could not be confirmed; however, the reported patient in-stent-thrombosis and neurological deficits are known risks associated with endovascular procedures and noted as such in the device directions for use (dfu).Therefore, an assignable cause of anticipated procedural complication was assigned to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROFORM ATLAS STENT SYSTEM 4.5 X 21MM WITHOUT TIP
Type of Device
STENT, INTRACRANIAL NEUROVASCULAR
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
MDR Report Key9205786
MDR Text Key162852282
Report Number3008881809-2019-00314
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
H020002/S046
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/14/2023
Device Catalogue NumberM003SZAS45210
Device Lot Number20471432
Was Device Available for Evaluation? No
Date Manufacturer Received11/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
XACT STENT (ABBOTT); ZILVER STENT (COOK MEDICAL)
Patient Outcome(s) Other; Required Intervention;
Patient Age64 YR
Patient Weight88
-
-